Vascular Pharmacology : Impact Factor & More
eISSN: 1879-3649pISSN: 1537-1891
Share this on:
Key Metrics
CiteScore 
10.3
Impact Factor
< 5
SJR
Q1Physiology
SNIP
1.47
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on Vascular Pharmacology
Vascular Pharmacology Journal Specifications
| Overview | |
| Publisher | ELSEVIER SCIENCE INC |
| Language | English |
| Frequency | Monthly |
| General Details | |
| Language | English |
| Frequency | Monthly |
| Publication Start Year | 2002 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Vascular Pharmacology ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Vascular Pharmacology
Transcellular permeability of arterial endothelium to plasma LDL, an underexplored target in treating atherosclerosis: Novel insights and potential treatment strategies.
- 1 Dec 2025
- Vascular pharmacology
Efficacy and safety of lorundrostat in patients with uncontrolled or resistant hypertension: A systematic review and meta-analysis with trial sequential analysis.
- 1 Dec 2025
- Vascular pharmacology
Nebivolol in the therapeutic landscape of heart failure: Mechanisms and clinical outcomes
- 1 Dec 2025
- Vascular Pharmacology
Apelin in glioblastoma: A dual target for tumor and vascular intervention.
- 1 Dec 2025
- Vascular pharmacology
Amylin receptors as therapeutic targets in obesity: Emerging peptide-based strategies
- 1 Dec 2025
- Vascular Pharmacology
Endothelial and non-endothelial actions of estrogen receptor subtypes in male and female mouse Aorta.
- 8 Nov 2025
- Vascular pharmacology
Transcellular permeability of arterial endothelium to plasma LDL, an underexplored target in treating atherosclerosis: Novel insights and potential treatment strategies.
- 1 Dec 2025
- Vascular pharmacology
Efficacy and safety of lorundrostat in patients with uncontrolled or resistant hypertension: A systematic review and meta-analysis with trial sequential analysis.
- 1 Dec 2025
- Vascular pharmacology
Nebivolol in the therapeutic landscape of heart failure: Mechanisms and clinical outcomes
- 1 Dec 2025
- Vascular Pharmacology
Apelin in glioblastoma: A dual target for tumor and vascular intervention.
- 1 Dec 2025
- Vascular pharmacology
Amylin receptors as therapeutic targets in obesity: Emerging peptide-based strategies
- 1 Dec 2025
- Vascular Pharmacology
Endothelial and non-endothelial actions of estrogen receptor subtypes in male and female mouse Aorta.
- 8 Nov 2025
- Vascular pharmacology
FAQs on Vascular Pharmacology
How long has Vascular Pharmacology been actively publishing? 
What is the publishing frequency of Vascular Pharmacology?
How many articles did Vascular Pharmacology publish last year?
What is the eISSN & pISSN for Vascular Pharmacology?
What is Citescore for Vascular Pharmacology?
What is SNIP score for Vascular Pharmacology?
What is the SJR for Vascular Pharmacology?
Who is the publisher of Vascular Pharmacology?
